Board Meetings for JBCHEPHARM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 23 May 2017 | Results/Dividend | inter alia, to consider and approve audited financial statement for the year ended on March 31, 2017 and also consider recommendation of dividend for the F.Y. 2016-17. | |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 23 May 2017 | Results/Buyback | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held May 23, 2017, inter alia, to consider and approve audited financial statement for the year ended on March 31, 2017 and also consider recommendation of dividend for the F.Y. 2016-17. The Company has now informed the Exchange that the Board will also consider the proposal for Buy-back of fully paid-up Equity Shares by the Company and other matters incidental thereto pursuant to Article 190 of the Articles of Association of the Company, provisions of Sections 68, 69 and 70 and other applicable provisions, if any, of the Companies Act, 2013 and the Securities and Exchange Board of India (Buy Back Securities) Regulations, 1998 as amended. (Purpose Revised) | |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 10 Feb 2017 | Results | To, inter alia, consider and approve unaudited financial results for the quarter ended on December 31, 2016. | |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 18 Nov 2016 | Results | To, inter alia, consider and approve unaudited financial results for the quarter ended on September 30, 2016. | |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 26 Aug 2016 | Results | To, inter alia, consider and approve unaudited financial results for the quarter ended on June 30, 2016. | |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 20 May 2016 | Results/Dividend | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held May 20 , 2016 inter alia, to consider and approve audited financial statements for the year ended on March 31, 2016. The Company has now informed the Exchange that the meeting of the Board of Directors would also consider recommendation of final dividend for the F.Y. 2015-16(purpose revised) | |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 20 May 2016 | Results | inter alia, to consider and approve audited financial statements for the year ended on March 31, 2016. | |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 11 Mar 2016 | Dividend | Inter alia, consider and declare interim dividend for the financial year 2015-16. | |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 03 Feb 2016 | Results | To consider and approve unaudited financial results for the quarter ended on December 31, 2015. | |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 04 Nov 2015 | Results | To consider and approve unaudited financial results for the quarter ended on September 30, 2015. | |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 05 Aug 2015 | Results | To consider and approve unaudited financial results for the quarter ended on June 30, 2015. | |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 20 May 2015 | Results/Dividend | To consider and approve annual audited financial results for the year ended on March 31, 2015. This is to further intimate the Exchange that the board of directors will also consider recommendation of dividend at the said meeting. | |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 04 Feb 2015 | Results | To consider and approve unaudited financial results for the quarter ending on December 31, 2014. | - |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 10 Nov 2014 | Results | to consider and approve unaudited financial results for the quarter ended on September 30, 2014. | - |
| JBCHEPHARM | JB Chemicals & Pharmaceuticals Limited | 05 Aug 2014 | Results | To consider and approve unaudited financial results for the quarter ending on June 30, 2014. | - |